MX9701342A - Formulacion cosolvente de tirilazad para administracion parenteral. - Google Patents

Formulacion cosolvente de tirilazad para administracion parenteral.

Info

Publication number
MX9701342A
MX9701342A MX9701342A MX9701342A MX9701342A MX 9701342 A MX9701342 A MX 9701342A MX 9701342 A MX9701342 A MX 9701342A MX 9701342 A MX9701342 A MX 9701342A MX 9701342 A MX9701342 A MX 9701342A
Authority
MX
Mexico
Prior art keywords
cosolvent
tirilazad
parenteral formulation
parenteral
formulation
Prior art date
Application number
MX9701342A
Other languages
English (en)
Inventor
Ching-Chiang Su
David S Baker
Susan M Machkovech
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MX9701342A publication Critical patent/MX9701342A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

La presente invencion se refiere a una formulacion farmacéutica cosolvente para administracion parenteral de un lazariode y sus sales farmacéuticamente aceptables.
MX9701342A 1994-09-01 1995-08-29 Formulacion cosolvente de tirilazad para administracion parenteral. MX9701342A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29937094A 1994-09-01 1994-09-01
US38225695A 1995-02-01 1995-02-01
PCT/US1995/010730 WO1996006618A1 (en) 1994-09-01 1995-08-29 Cosolvent parenteral formulation of tirilazad

Publications (1)

Publication Number Publication Date
MX9701342A true MX9701342A (es) 1997-05-31

Family

ID=26971187

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701342A MX9701342A (es) 1994-09-01 1995-08-29 Formulacion cosolvente de tirilazad para administracion parenteral.

Country Status (23)

Country Link
US (1) US5858999A (es)
EP (1) EP0778775B1 (es)
JP (1) JPH10505063A (es)
KR (1) KR100359556B1 (es)
CN (1) CN1156962A (es)
AT (1) ATE175875T1 (es)
AU (1) AU696856B2 (es)
BR (1) BR9508655A (es)
CA (1) CA2196063A1 (es)
CZ (1) CZ283875B6 (es)
DE (1) DE69507493T2 (es)
DK (1) DK0778775T3 (es)
ES (1) ES2128761T3 (es)
FI (1) FI970858A0 (es)
GR (1) GR3029396T3 (es)
HU (1) HUT76808A (es)
MX (1) MX9701342A (es)
NO (1) NO311405B1 (es)
NZ (1) NZ292690A (es)
PL (1) PL181244B1 (es)
RU (1) RU2152789C2 (es)
SK (1) SK280278B6 (es)
WO (1) WO1996006618A1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
DE69922252T2 (de) * 1999-01-28 2005-12-01 Patel, Dinesh Shantilal Parenterale lösungen enthaltend propofol (2,6-diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol als lösungsmittel
DE10010073B4 (de) 2000-02-28 2005-12-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verankerung für implantierbare Herzklappenprothesen
DE10010074B4 (de) 2000-02-28 2005-04-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vorrichtung zur Befestigung und Verankerung von Herzklappenprothesen
FR2828263B1 (fr) 2001-08-03 2007-05-11 Philipp Bonhoeffer Dispositif d'implantation d'un implant et procede d'implantation du dispositif
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
AU2004304716B2 (en) * 2003-12-18 2010-05-27 Biomas Ltd. Tellurium derivatives for prevention and treatment of neurodegenerative processes
EP1796660B1 (en) 2004-09-17 2016-11-23 BioMAS Ltd. Use of ammonium trichloro(dioxyethylene-o,o')tellurate (as101) for the inhibition of interleukin-1beta-converting enzyme
EP2471536A1 (en) * 2004-09-29 2012-07-04 Harbor BioSciences, Inc. Steroid analogs and characterization and treatment methods
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
DE102005051849B4 (de) 2005-10-28 2010-01-21 JenaValve Technology Inc., Wilmington Vorrichtung zur Implantation und Befestigung von Herzklappenprothesen
DE102005052628B4 (de) 2005-11-04 2014-06-05 Jenavalve Technology Inc. Selbstexpandierendes, flexibles Drahtgeflecht mit integrierter Klappenprothese für den transvaskulären Herzklappenersatz und ein System mit einer solchen Vorrichtung und einem Einführkatheter
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9138315B2 (en) 2007-04-13 2015-09-22 Jenavalve Technology Gmbh Medical device for treating a heart valve insufficiency or stenosis
US9295551B2 (en) 2007-04-13 2016-03-29 Jenavalve Technology Gmbh Methods of implanting an endoprosthesis
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US9168130B2 (en) 2008-02-26 2015-10-27 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8465540B2 (en) 2008-02-26 2013-06-18 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
US8317858B2 (en) 2008-02-26 2012-11-27 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8398704B2 (en) 2008-02-26 2013-03-19 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
BR112012021347A2 (pt) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent para posicionamento e ancoragem de uma prótese valvular em um local de implantação no coração de um paciente
ES2548138T3 (es) 2008-05-28 2015-10-14 Reveragen Biopharma, Inc. Moduladores esteroideos no hormonales de NF-kappaB para el tratamiento de enfermedades
US8468667B2 (en) 2009-05-15 2013-06-25 Jenavalve Technology, Inc. Device for compressing a stent
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
US11278406B2 (en) 2010-05-20 2022-03-22 Jenavalve Technology, Inc. Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
BR112012029896A2 (pt) 2010-05-25 2017-06-20 Jenavalve Tech Inc válcula cardíaca protética para endoprótese e endoprótese
CA2852369A1 (en) 2011-10-21 2013-04-25 Jenavalve Technology Inc. Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect
DE202013011734U1 (de) 2012-05-16 2014-04-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter-Zuführsystem zum Einführen einer expandierbaren Herzklappenprothese sowie medizinische Vorrichtung zum Behandeln eines Herzklappendefekts
CN103861090B (zh) * 2012-12-18 2017-06-13 美迪思生物科技(北京)有限公司 含蛋白或多肽的疏水溶液、其制备方法及用途
EP4098226A1 (en) 2013-08-30 2022-12-07 JenaValve Technology, Inc. Endoprosthesis comprising a radially collapsible frame and a prosthetic valve
WO2016177562A1 (en) 2015-05-01 2016-11-10 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
CN109475419B (zh) 2016-05-13 2021-11-09 耶拿阀门科技股份有限公司 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195918B (en) * 1984-03-14 1988-08-29 Jerome Corbiere Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components
US5175281A (en) * 1985-09-12 1992-12-29 The Upjohn Company Pharmaceutically active pyrimidinylpiperazinylsterioids
WO1987001706A2 (en) * 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
US4968675A (en) * 1988-10-28 1990-11-06 Upjohn Non-hemolytic lazaroid parenteral formulation
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
JP2002500616A (ja) * 1994-07-21 2002-01-08 ファルマシア・アンド・アップジョン・カンパニー 神経学的に活性なアミノステロイド
US5614515A (en) * 1994-11-17 1997-03-25 University Of Southern California Lazaroid-based compositions and method for preventing adhesion formation using the same

Also Published As

Publication number Publication date
ATE175875T1 (de) 1999-02-15
CZ283875B6 (cs) 1998-06-17
EP0778775A1 (en) 1997-06-18
JPH10505063A (ja) 1998-05-19
CZ55997A3 (en) 1997-06-11
NO970935L (no) 1997-04-11
PL181244B1 (pl) 2001-06-29
SK26297A3 (en) 1997-09-10
EP0778775B1 (en) 1999-01-20
PL318901A1 (en) 1997-07-21
NZ292690A (en) 1998-06-26
FI970858A (fi) 1997-02-28
FI970858A0 (fi) 1997-02-28
NO311405B1 (no) 2001-11-26
CA2196063A1 (en) 1996-03-07
AU696856B2 (en) 1998-09-17
DE69507493T2 (de) 1999-06-10
KR100359556B1 (ko) 2002-12-18
RU2152789C2 (ru) 2000-07-20
DE69507493D1 (de) 1999-03-04
WO1996006618A1 (en) 1996-03-07
ES2128761T3 (es) 1999-05-16
CN1156962A (zh) 1997-08-13
AU3493895A (en) 1996-03-22
NO970935D0 (no) 1997-02-28
HUT76808A (en) 1997-11-28
SK280278B6 (sk) 1999-10-08
GR3029396T3 (en) 1999-05-28
US5858999A (en) 1999-01-12
BR9508655A (pt) 1997-08-12
DK0778775T3 (da) 1999-09-13

Similar Documents

Publication Publication Date Title
MX9701342A (es) Formulacion cosolvente de tirilazad para administracion parenteral.
BG101901A (en) 2-methyl-thieno-benzodiazepine formulation for oral application
TW350844B (en) Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases
AU7237394A (en) Morphinan derivative and medicinal use
MY114389A (en) Aqueous risperidone formulations
IL122215A0 (en) Dolastatin derivatives their preparation and use
EP0840606A4 (es)
ZA962881B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
AU3769297A (en) Dolastatin pentapeptide derivatives and their use as antitumor agents
AU2882792A (en) Tripeptide derivative anti-inflammatory agents
AU4517893A (en) An oral formulation for gastric antibacterial treatment as well as a process thereof and the use
PL327238A1 (en) Derivatives of cyclopeptides
HUP9600498A3 (en) Antimigrane 1,2,5-thiadiazole derivatives of 1-indolylalkyl-4-pyridinyl and -4-pyrimidinylpiperazines and pharmaceutical compositions containing the same
AU1466097A (en) Protected biopolymers for oral administration and methods of using same
HUP9900089A3 (en) Peptide derivatives of dolastatin 15
GB9410237D0 (en) Inactivation of cytotoxic drugs
AU3909389A (en) Il-1alpha derivatives and medicament for treating thrombocytopenia
AU3347493A (en) Pharmaceutically active substituted benzimidazole derivatives
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
AU2137395A (en) Use of cyclic depsipeptides with 18 ring atoms
AU3656493A (en) Restroom organizer and sterilizing apparatus
NZ319746A (en) A synergisitic combination of a beta-receptor blocker and an opioid
MX9706825A (es) El uso farmacologico de ciertos derivados de cistina.
BR9712628A (pt) Derivados de 8(9)-deidroestradiol
AU4730296A (en) Device for prevention and removal of precipitous deposition in the human body